Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Salivary Gland Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Tongue Neoplasms 5Rectal Neoplasms 3Pancreatic Neoplasms 3Esthesioneuroblastoma, Olfactory 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Pharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Tonsillar Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Parotid Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1

Interventions

Radiotherapy 3Cisplatin 3Specimen Handling 2Magnetic Resonance Spectroscopy 2Hydroxyurea 2Fluorouracil 2Drug Therapy 2Docetaxel 2Celecoxib 2toripalimab 1antineoplaston AS 2-1 1antineoplaston A10 1X-Rays 1Therapeutics 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Platinum 1Observation 1Nivolumab 1Ipilimumab 1Eucalyptus Oil 1Erlotinib Hydrochloride 1Coal Tar 1Chemoprevention 1Cetuximab 1Carboplatin 1CTLA-4 Antigen 1CP protocol 1Behavior Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paranasal Sinus Neoplasms × Erlotinib Hydrochloride × Head & Neck × Clear all
NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
15 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡